α-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast

Genetics

Volumn 170, Issue 1, 2005, Pages 47-59

  Dixon, Cheryl ^a   Mathias, Neal ^a   Zweig, Richard M ^b   Davis, Donnie A ^a   Gross, David S ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PROTEASOME;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL INCLUSION; CELL MEMBRANE; CYTOTOXICITY; DISEASE COURSE; GENE LOCUS; GENETIC LINKAGE; LEWY BODY; NONHUMAN; PARKINSON DISEASE; POINT MUTATION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; QUALITY CONTROL; SACCHAROMYCES CEREVISIAE; UBIQUITINATION; YEAST;

AMINO ACID SUBSTITUTION; CELL MEMBRANE; CYTOPLASM; GENES, REPORTER; HEAT; MUTATION; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES CEREVISIAE;

EID: 20444372698     PISSN: 00166731     EISSN: None     Source Type: Journal    
DOI: 10.1534/genetics.104.035493     Document Type: Article

References (64)

1. BABU, P., J. D. BRYAN, H. R. PANEK, S. L. JORDAN, B. M. FORBRICH et al., 2002 Plasma membrane localization of the Yck2p yeast casein kinase 1 isoform requires the C-terminal extension and secretory pathway function. J. Cell Sci. 115: 4957-4968.
2. BANKAITIS, V. A., D. E. MALEHORN, S. D. EMR and R. GREENE, 1989 The Saccharomyces cerevisiae SEC14 gene encodes a cytosolic factor that is required for transport of secretory proteins from the yeast Golgi complex. J. Cell Biol. 108: 1271-1281.
3. BARLOWE, C., L. ORCI, T. YEUNG, M. HOSOBUCHI, S. HAMAMOTO et al., 1994 COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell 77: 895-907.
4. BENCE, N. F., R. M. SAMPAT and R. R. KOPITO, 2001 Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292: 1552-1555.
5. BERKE, S. J., and H. L. PAULSON, 2003 Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Curr. Opin. Genet. Dev. 13: 253-261.
6. BETARBET, R., T. B. SHERER, D. A. DI MONTE and J. T. GREENAMYRE, 2002a Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol. 12: 499-510.
7. BETARBET, R., T. B. SHERER and J. T. GREENAMYRE, 2002b Animal models of Parkinson's disease. BioEssays 24: 308-318.
8. BRENNWALD, P., B. KEARNS, K. CHAMPION, S. KERANEN, V. BANKAITIS et al., 1994 Sec9 is a SNAP-25-like component of a yeast SNARE complex that may be the effector of Sec4 function in exocytosis. Cell 79: 245-258.
9. BUSSELL, R., JR., and D. ELIEZER, 2003 A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. J. Mol. Biol. 329: 763-778.
10. BUSSELL, R., JR., and D. ELIEZER, 2004 Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein. Biochemistry 43: 4810-4818.
11. CABIN, D. E., K. SHIMAZU, D. MURPHY, N. B. COLE, W. GOTTSCHALK et al., 2002 Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22: 8797-8807.
12. CHANDRA, S., X. CHEN, J. RIZO, R. JAHN and T. C. SUDHOF, 2003 A broken alpha-helix in folded alpha-Synuclein. J. Biol. Chem. 278: 15313-15318.
13. COLE, N. B., D. D. MURPHY, T. GRIDER, S. RUETER, D. BRASAEMLE et al., 2002 Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein. J. Biol. Chem. 277: 6344-6352.
14. DIXON, C., L. E. BRUNSON, M. M. ROY, D. SMOTHERS, M. G. SEHORN et al., 2003 Overproduction of polypeptides corresponding to the amino terminus of the F-box proteins Cdc4p and Met30p inhibits ubiquitin ligase activities of their SCF complexes. Eukaryot. Cell 2: 123-133.
15. ELBLE, R., 1992 A simple and efficient procedure for transformation of yeasts. Biotechniques 13: 18-20.
16. ERKINE, A. M., and D. S. GROSS, 2003 Dynamic chromatin alterations triggered by natural and synthetic activation domains. J. Biol. Chem. 278: 7755-7764.
17. FEANY, M. B., and W. W. BENDER, 2000 A Drosophila model of Parkinson's disease. Nature 404: 394-398.
18. FERRO-NOVICK, S., and R. JAHN, 1994 Vesicle fusion from yeast to man. Nature 370: 191-193.
19. GEORGE, J. M., H. JIN, W. S. WOODS and D. F. CLAYTON, 1995 Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15: 361-372.
20. GETHING, M. J., 1997 Protein folding. The difference with prokaryotes. Nature 388: 329, 331.
21. GOSAVI, N., H. J. LEE, J. S. LEE, S. PATEL and S. J. LEE, 2002 Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J. Biol. Chem. 277: 48984-48992.
22. HEINEMEYER, W., J. A. KLEINSCHMIDT, J. SAIDOWSKY, C. ESCHER and D. H. WOLF, 1991 Proteinase yscE, the yeast proteasome/multicatalytic-multifunctional proteinase: mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival. EMBO J. 10: 555-562.
23. HEINEMEYER, W., A. GRUHLER, V. MOHRLE, Y. MAHE and D. H. WOLF, 1993 PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chrymotryptic activity and degradation of ubiquitinated proteins. J. Biol. Chem. 268: 5115-5120.
24. HOYER, W., D. CHERNY, V. SUBRAMANIAM and T. M. JOVIN, 2004 Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry 43: 16233-16242.
25. HUGHES, R. E., R. S. LO, C. DAVIS, A. D. STRAND, C. L. NEAL et al., 2001 Altered transcription in yeast expressing expanded polyglutamine. Proc. Natl. Acad. Sci. USA 98: 13201-13206.
26. IRIZARRY, M. C., T. W. KIM, M. MCNAMARA, R. E. TANZI, J. M. GEORGE et al., 1996 Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J. Neuropathol. Exp. Neurol. 55: 889-895.
27. JENNER, P., and C. W. OLANOW, 1998 Understanding cell death in Parkinson's disease. Ann. Neurol. 44: S72-S84.
28. JENSEN, P. H., M. S. NIELSEN, R. JAKES, C. G. DOTTI and M. GOEDERT, 1998 Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J. Biol. Chem. 273: 26292-26294.
29. JO, E., N. FULLER, R. P. RAND, P. ST. GEORGE-HYSLOP and P. E. FRASER, 2002 Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. J. Mol. Biol. 315: 799-807.
30. KAHLE, P. J., M. NEUMANN, L. OZMEN, V. MULLER, H. JACOBSEN et al., 2000 Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. J. Neurosci. 20: 6365-6373.
31. KIM, J., 1997 Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil. Mol. Cells 7: 78-83.
32. KITADA, T., S. ASAKAWA, N. HATTORI, H. MATSUMINE, Y. YAMAMURA et al., 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608.
33. KROBITSCH, S., and S. LINDQUIST, 2000 Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl. Acad. Sci. USA 97: 1589-1594.
34. KRUGER, R., W. KUHN, T. MULLER, D. WOITALLA, M. GRAEBER et al., 1998 Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18: 106-108.
35. LEHMAN, K., G. ROSSI, J. E. ADAMO and P. BRENNWALD, 1999 Yeast homologues of tomosyn and lethal giant larvae function in exocytosis and are associated with the plasma membrane SNARE, Sec9. J. Cell Biol. 146: 125-140.
36. LINDERSSON, E., R. BEEDHOLM, P. HOJRUP, T. MOOS, W. GAI et al., 2004 Proteasomal inhibition by alpha-synuclein filaments and oligomers. J. Biol. Chem. 279: 12924-12934.
37. LINDQUIST, S., 1997 Mad cows meet psi-chotic yeast: the expansion of the prion hypothesis. Cell 89: 495-498.
38. LUCKING, C. B., and A. BRICE, 2000 Alpha-synuclein and Parkinson's disease. Cell. Mol. Life Sci. 57: 1894-1908.
39. MAROTEAUX, L., J. T. CAMPANELLI and R. H. SCHELLER, 1988 Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8: 2804-2815.
40. MASLIAH, E., E. ROCKENSTEIN, I. VEINBERGS, M. MALLORY, M. HASHIMOTO et al., 2000 Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287: 1265-1269.
41. MATSUOKA, Y., M. VILA, S. LINCOLN, A. MCCORMACK, M. PICCIANO et al., 2001 Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol. Dis. 8: 535-539.
42. MCDANIEL, D., A. J. CAPLAN, M. S. LEE, C. C. ADAMS, B. R. FISHEL et al., 1989 Basal-level expression of the yeast HSP82 gene requires a heat shock regulatory element. Mol. Cell. Biol. 9: 4789-4798.
43. MCLEAN, P. J., H. KAWAMATA, S. RIBICH and B. T. HYMAN, 2000 Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. J. Biol. Chem. 275: 8812-8816.
44. MCNAUGHT, K. S., L. M. BJORKLUND, R. BELIZAIRE, O. ISACSON, P. JENNER et al., 2002 Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport 13: 1437-1441.
45. MITCHELL, D. A., T. K. MARSHALL and R. J. DESCHENES, 1993 Vectors for the inducible overexpression of glutathione S-transferase fusion proteins in yeast. Yeast 9: 715-722.
46. MORI, F., C. INENAGA, M. YOSHIMOTO, H. UMEZU, R. TANAKA et al., 2002 Alpha-synuclein immunoreactiviry in normal and neoplastic Schwann cells. Acta Neuropathol. 103: 145-151.
47. NISHIMURA, N., S. BANNYKH, S. SLABOUGH, J. MATTESON, Y. ALTSCHULER et al., 1999 A di-acidic (DXE) code directs concentration of cargo during export from the endoplasmic reticulum. J. Biol. Chem. 274: 15937-15946.
48. NORMAN, G. R., and D. L. STREINER, 2000 Biostatistics: The Bare Essentials. B. C. Decker, London.
49. NOVICK, P., C. FIELD and R. SCHEKMAN, 1980 Identification of 23 complementation groups required for post-translational events in the yeast secretory pathway. Cell 21: 205-215.
50. OUTEIRO, T. F., and S. LINDQUIST, 2003 Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302: 1772-1775.
51. POLYMEROPOULOS, M. H., 1998 Autosomal dominant Parkinson's disease. J. Neurol. 245: 1-3.
52. POLYMEROPOULOS, M. H., C. LAVEDAN, E. LEROY, S. E. IDE, A. DEHEJIA et al., 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
53. RAITT, D. C., A. L. JOHNSON, A. M. ERKINE, K. MAKINO, B. MORGAN et al., 2000 The Skn7 response regulator of Saccharomyces cerevisiae interacts with Hsfl in vivo and is required for the induction of heat shock genes by oxidative stress. Mol. Biol. Cell 11: 2335-2347.
54. ROCHET, J. C., T. F. OUTEIRO, K. A. CONWAY, T. T. DING, M. J. VOLLES et al., 2004 Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease. J. Mol. Neurosci. 23: 23-34.
55. ROSE, M. D., F. WINSTON and P. HIETER, 1990 A Laboratory Course. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
56. ROTHMAN, J. E., 1994 Mechanisms of intracellular protein transport. Nature 372: 55-63.
57. SHIMURA, H., M. G. SCHLOSSMACHER, N. HATTORI, M. P. FROSCH, A. TROCKENBACHER et al., 2001 Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293: 263-269.
58. SINGLETON, A. B., M. FARRER, J. JOHNSON, A. SINGLETON, S. HAGUE et al., 2003 alpha-Synuclein locus triplication causes Parkinson's disease. Science 302: 841.
59. SPILLANTINI, M. G., M. L. SCHMIDT, V. M. LEE, J. Q. TROJANOWSKI, R. JAKES et al., 1997 Alpha-synuclein in Lewy bodies. Nature 388: 839-840.
60. SYME, C. D., E. W. BLANCH, C. HOLT, R. JAKES, M. GOEDERT et al., 2002 A Raman optical activity study of rheomorphism in caseins, synucleins and tau. New insight into the structure and behaviour of natively unfolded proteins. Eur. J. Biochem. 269: 148-156.
61. TANAKA, Y., S. ENGELENDER, S. IGARASHI, R. K. RAO, T. WANNER et al., 2001 Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10: 919-926.
62. TAYLOR, J. P., J. HARDY and K. H. FISCHBECK, 2002 Toxic proteins in neurodegenerative disease. Science 296: 1991-1995.
63. VAN DER PUTTEN, H., K. H. WIEDERHOLD, A. PROBST, S. BARBIERI, C. MISTL et al., 2000 Neuropathology in mice expressing human alpha-synuclein. J. Neurosci. 20: 6021-6029.
64. WEINREB, P. H., W. ZHEN, A. W. POON, K. A. CONWAY and P. T. LANSBURY, JR., 1996 NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35: 13709-13715.